NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ:CYTK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants […]

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or the "Company") (NYSE:BAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ:SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Today, American Global Strategies LLC announced the addition ofJason Chaffetz to the firm as a Senior Advisor. Mr. Chaffetz brings decades of experience in public service, media, and private sector leadership to AGS's growing team of experts. https://mma.prnewswire.com/media/2819323/American_Global_Strategies_Jason_Chaffetz_Senior_Advisor.jpg Mr. Chaffetz was elected to the United States House of Representatives in 2008 from Utah's Third District

(NASDAQ:ZBIO), WALTHAM, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced management's presentations at the following investor conferences: Jefferies Global Healthcare Conference

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences GlobeNewswire November 11, 2025 WALTHAM, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against VF Corp. ("VFC" or "the Company") (NYSE:VFC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010,

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marex Group plc ("Marex" or "the Company") (NASDAQ:MRX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against